Authors
Sebastien Fierens, Helene Mairesse, Jean-Francois Heilier, Claire De
Burbure, Jean-Francois Focant, Gauthier Eppe, Edwin De Pauw, Alfred
Bernard.
Title:
Dioxin/ polychlorinated biphenyl body burden, diabetes and endometriosis:
findings in a population-based study in Belgium.
Journal:
Biomarkers 8: 529-534, 2003.
Summary:
Persistent organic pollutants such as polychlorinated dibenzodioxins/
dibenzofurans (PCDD/F's or dioxins) and polychlorinated biphenyls (PCBs)
accumulate in the food chain and the human body. In spite of the decreased
burden of these pollutants in general population, a matter of concern
is the effects of elevated levels of these chemicals in highly exposed
populations. Current evidence is suggestive of a possible relationship
between halogenated aromatic compounds and chronic diseases like endometriosis
and diabetes.
The present study
examined the risk of diabetes and endometriosis in people living near
pollution sources in Belgium that are exposed to organic pollutants,
dioxins and PCBs. For this study, 257 subjects (142 women and 115 men)
were recruited from 2000-2001 from those living in the vicinity of an
iron and steel plant (Cockerill-58 subjects), a waste dumping site (Mont-Saint-Guibert-52
subjects), a municipal solid waste incinerator in an industrial area
(Pont-de-Loup-33 subjects), and in a rural area (Thumaide-51 subjects).
Controls were not living near a pollution source in rural areas of southern
Belgium (Daverdisse, Nassogne & Bertrix-63 subjects). All study
volunteers, lived in the above mentioned areas of Belgium for a prolonged
period of time and consumed locally produced food. Subjects with possible
occupational exposure to these pollutants, such as workers in above
mentioned plants, were excluded. Information on health status (diabetes,
endometriosis), as well as a range of demographic and behavioural factors
were obtained by a self-administered questionnaire. The concentrations
of seventeen PCCD/F's, four dioxin-like non-ortho-PCBs (coplanar PCBs)
and twelve PCB markers were assessed from a fasting blood sample and
measured using gas chromatography-high resolution mass spectrometry
(GC-HRMS) on the lipid fraction of the serum. Dioxin & coplanar
PCB were expressed in toxic equivalents (TEQs) where as PCB markers
were expressed in ng/g fat. A total of 9 cases of diabetes and 10 cases
of endometriosis were observed.
In this study,
the cases of diabetes and endometriosis were found to be well matched
with controls for age, BMI and serum lipids. Moreover no significant
differences were observed in weight loss and fat intake between cases
and controls. Analysis on women did not reveal any significant association
between dioxin/ PCB levels and endometriosis whereas analysis of the
entire population identified diabetes as a significant determinant of
serum levels of dioxin, coplanar PCB and 12 PCB markers. In addition
to above findings the odds ratios (OR) and 95% confidence intervals
(CI) estimated by dividing the entire population into two groups, using
90th percentile of the adjusted concentrations of dioxin, coplanar PCB
and PCB markers revealed significant estimates for the relationship
between diabetes and dioxins (OR=5.07, CI:1.18-21.7), coplanar PCBs
(OR=13.3, CI:3.31-53.2) and 12 PCB markers (OR=7.58, CI:1.58-36.3).
Overall, this study
found a significant relationship between dioxins/ PCBs concentrations
in the body and diabetes but not endometriosis. But, these results should
be interpreted with caution as the analysis was based on very few cases.
However, the analysis of highly exposed endometriosis cases, in this
study (cases living near incinerators) as well as in another study with
a larger sample size, could not establish any formal relationship between
dioxin/ PCB concentrations and endometriosis. For diabetes, even though
the results and prior evidence were suggestive of a relationship with
body burden of dioxins and PCBs, the direction of causality still has
to be established. The higher levels of these pollutants in diabetics
could be a consequence of diabetes induced metabolic alterations leading
to slow elimination of these lipophilic compounds. However, dioxin half-life
in diabetics and non-diabetics was identified to be similar, providing
argument against the hypothesis of slow elimination.